Thus, close attention should be paid to the following two points when using PRL and ART drugs in HIV‐infected patients: (I) the glucose level in the cerebrospinal fluid, which may be an indicator of CNS injury and (II) energy metabolism disorder, which should be treated to avoid structural damage to the CNS. This evidence concerns the gene PRL and Disorder of energy metabolism.